leisure time -WSS

leisure time

author：explore 2025-09-28 23:29:17 - browse：9

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medicare drug price negotiation’s day in court

WSS

Vertigo drug brings hope for rare neuron disorder, Niemann

Medicare drug price negotiation’s day in court

Lawmakers grill UnitedHealth CEO on Change cyberattack

Cognito secures funding to test medical device for Alzheimer's

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Deliver public health messages at the right time

focus

leisure time

focus

After affirmative action ruling, medical educators look to 'holistic review'

Vertigo drug brings hope for rare neuron disorder, Niemann

Cancer drug shortages should be causing more outrage

Congressmen charge Covid hearing ‘could have been an email’

Heart attack and stroke risk calculators need revising

Lawmakers grill UnitedHealth CEO on Change cyberattack

Virginia high school admissions case could be legal follow

Can gargling with Listerine treat gonorrhea of the mouth?

Alkermes shareholders re

Crowdfunding for medical bills sidesteps core problem, author says

focus

Vertigo drug brings hope for rare neuron disorder, Niemann

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Novel spinal cord stimulator treats paralysis without surgery

Some dementia cases could be undiagnosed liver disease

Can gargling with Listerine treat gonorrhea of the mouth?

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

focus

leisure time

hotspot

explore